Análise Histórico-Normativa do Fundo de Desenvolvimento da Amazônia

Abstract

The Amazon Development Fund (FDA) is an important instrument of action of the National Regional Development Policy (PNDR) in the Legal Amazon, being an inducer of large productive enterprises for the region. Some conditions of its system may harm the Fund's attractiveness to credit seekers in the region and financial institutions able to act as operating agents. This work analyzes these conditions from normative, technical and project approval aspects, using data extracted from FDA technical reports prepared by Sudam and technical reports from Condel/SUDAM, PRDA and CGU. With this, the following research problem arises: What aspects have a negative impact on the attractiveness of the FDA? The theoretical framework addresses the main theories on regional development, the main government interventions in terms of development in the Amazon, from the creation of SPVEA and SUDAM in 1966 until their extinction in 2001 and recreation in 2007, in parallel with an analysis of the funds that preceded the creation of the FDA, covering the main aspects of governance and management and the main characteristics that differentiate them. Next, the work analyzes the regulatory history that has guided the FDA's system since its creation, detailing 5 operational difficulties listed based on the report data. As results, the work presents a proposal to increase the remuneration of the operating agent associated with the risk assumed, increase the maximum FDA financing limits, decrease the project contracting period and indicate the establishment of a minimum percentage to be contributed annually by the STN in the FDA.